InChI=1S/C25H36O7/c1- 12- 10- 23(29) 24(30,22(28) 15(4) 8- 18- 19(26) 9- 14(3) 21(18) 27) 20- 13(2) 6- 7- 17(20) 16(5) 25(23,31) 32- 11- 12/h9- 10,13,15- 20,26,29- 31H,6- 8,11H2,1- 5H3/t13- ,15+,16- ,17- ,18+,19- ,20+,23- ,24- ,25- /m1/s1 |
WREVESBXGFRQJD-PHRJMFLCSA-N |
[H] [C@] 12CC[C@@H] (C) [C@] 1([H] ) [C@@] (O) (C(=O) [C@@H] (C) C[C@H] 1[C@H] (O) C=C(C) C1=O) [C@] 1(O) C=C(C) CO[C@] 1(O) [C@@H] 2C |
|
Leucosceptrum canum
(NCBI:txid694369)
|
Found in
aerial part
(BTO:0001658).
See:
PubMed
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
Any EC 3.4.21.* (serine endopeptidase) inhibitor that interferes with the action of prolyl oligopeptidase (EC 3.4.21.26).
|
|
angiogenesis inhibitor
An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
|
|
(4R,5S)- 4- hydroxy- 2- methyl- 5- {(2S)- 2- methyl- 3- oxo- 3- [(4aR,5S,5aS,6R,8aS,9R,9aR)- 4a,5,9a- trihydroxy- 3,6,9- trimethyl- 2,4a,5,5a,6,7,8,8a,9,9a- decahydrocyclopenta[g]chromen- 5- yl]propyl}cyclopent- 2- en- 1- one
|